Although SFRP1 is downregulated in most breast cancers, this is not the case in the medullary type often associated with triple-negative breast cancers (TNBC), characterised by their lack of hormone receptors ER/PR and HER2. This evidence concerns the gene ERBB2 and breast carcinoma.